Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early‐onset Alzheimer's disease

Abstract Introduction People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS. Methods Noradrenaline, adrenaline, and their metabolite 3‐methoxy‐4‐hydr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Alain D. Dekker, Yannick Vermeiren, Maria Carmona‐Iragui, Bessy Benejam, Laura Videla, Ellen Gelpi, Tony Aerts, Debby Van Dam, Susana Fernández, Alberto Lleó, Sebastian Videla, Anne Sieben, Jean‐Jacques Martin, Netherlands Brain Bank, Rafael Blesa, Juan Fortea, Peter P. De Deyn
Materialtyp: Artigo
Språk:Inglês
Publicerad: Wiley 2018-01-01
Serie:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Ämnen:
Alzheimer's disease
Cerebrospinal fluid
Dementia
Dopamine
Down syndrome
Monoamines
Länkar:https://doi.org/10.1016/j.dadm.2017.11.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk